Knights of Columbus Asset Advisors’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-48
Closed -$19.3K 414
2024
Q1
$19.3K Sell
48
-49
-51% -$18.2K ﹤0.01% 357
2023
Q4
$33.8K Buy
97
+49
+102% +$17.3K ﹤0.01% 362
2023
Q3
$21.5K Hold
48
﹤0.01% 366
2023
Q2
$35.3K Hold
48
﹤0.01% 364
2023
Q1
$36.4K Hold
48
﹤0.01% 350
2022
Q4
$92.2K Buy
+48
New +$19K 0.01% 316
2022
Q3
Sell
-48
Closed -$36K 326
2022
Q2
$36K Hold
48
﹤0.01% 313
2022
Q1
$167K Sell
48
-49
-51% -$128K 0.01% 285
2021
Q4
$293K Buy
97
+2
+2% +$9.28K 0.02% 262
2021
Q3
$620K Hold
95
0.06% 239
2021
Q2
$1.25M Buy
95
+15
+19% +$236K 0.12% 223
2021
Q1
$1.35M Buy
80
+12
+18% +$234K 0.13% 229
2020
Q4
$1.15M Buy
68
+28
+70% +$527K 0.12% 241
2020
Q3
$745K Buy
+40
New +$919K 0.09% 249

Other funds holding KALA

Knights of Columbus Asset Advisors's KALA Position: Q2 2024 in Review

Knights of Columbus Asset Advisors sold out of KALA BIO (KALA) in Q2 2024, closing a stake of 48 shares — an estimated $19.3K sold.

Knights of Columbus Asset Advisors first reported a position in KALA in Q3 2020 and held it in 14 quarters. The position peaked at $1.35M in Q1 2021. 25 funds tracked by Wall St. Rank hold KALA as of Q2 2024.

  • Knights of Columbus Asset Advisors reported no remaining KALA BIO position as of Q2 2024 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 48 KALA BIO shares in Q2 2024, an estimated $19.3K.
  • Knights of Columbus Asset Advisors first reported a position in KALA BIO in Q3 2020 and held it in 14 quarters.
  • Knights of Columbus Asset Advisors's KALA BIO position peaked at $1.35M in Q1 2021.
  • 25 funds tracked by Wall St. Rank held KALA BIO as of Q2 2024.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2024, filed 30 Jul 2024.